metyrapone has been researched along with Deaf Mutism in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duckworth, WC | 1 |
Kitabchi, AE | 1 |
Crandall, BF | 1 |
Samec, L | 1 |
Sparkes, RS | 1 |
Wright, SW | 1 |
2 other studies available for metyrapone and Deaf Mutism
Article | Year |
---|---|
Inadequate adrenal reserve.
Topics: 17-Ketosteroids; Adrenal Insufficiency; Adrenocorticotropic Hormone; Aged; Deafness; Glucocorticoids | 1971 |
A familial syndrome of deafness, alopecia, and hypogonadism.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Alopecia; Deafness; Dermatoglyphics; | 1973 |